
Jon Decker: AARP’s support for Medicare “negotiation” not in seniors’ interest
In a recent op-ed discussing health care and inflation, AARP’s West Virginia chapter called for a Medicare “negotiation” scheme to address prescription drug prices. This tired proposal would be disastrous for pharmaceutical innovation – and, ultimately, for the seniors the AARP claims to represent. Medicare negotiation is tantamount to government-imposed price controls, forcing manufacturers to set prices on certain medications at the government’s direction or face a 95 percent excise tax. And while the AARP…
Learn More